Showing results (221-230 of 242) with videos related to
Sort By:
Pageof 25
The Journal of Clinical Investigation|October 1, 1992
Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alphaS Isonishi, A P Jekunen, D K Hom, et al.Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancerM Andersson, K F Aronsen, C Balch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancerS B Howell, S Kirmani, W E Lucas, et al.International Journal of Cancer|August 4, 1998
Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatinD Fink, S Nebel, P S Norris, et al.Cancer Research|November 1, 1991
Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatinS Isonishi, D K Hom, F B Thiebaut, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formationG Los, f A Blommaert, R Barton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinomaA Bonetti, M Zaninelli, R Leone, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.Cancer Research|July 1, 1996
Loss of DNA mismatch repair in acquired resistance to cisplatinS Aebi, B Kurdi-Haidar, R Gordon, et al.Pageof 25